<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00852410</url>
  </required_header>
  <id_info>
    <org_study_id>09-0001-A</org_study_id>
    <nct_id>NCT00852410</nct_id>
  </id_info>
  <brief_title>The Hemostatic and Hemodynamic Effects of Adrenaline During Endoscopic Sinus Surgery</brief_title>
  <official_title>The Hemostatic and Hemodynamic Effects of Adrenaline During Endoscopic Sinus Surgery: Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obtaining adequate hemostasis is crucial during endoscopic sinus surgery. Submucosal
      injection of local anaesthetic containing adrenaline has frequently been used to improve
      surgical milieu. However, injection of adrenaline has potential side effects including
      tachycardia, hypertension as well as inducing arrhythmia. The aim of this randomized clinical
      trial is to assess the hemodynamic and hemostatic effects of two different concentrations of
      adrenaline in local anaesthetic used during endoscopic sinus surgery.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2009</start_date>
  <completion_date type="Anticipated">April 2010</completion_date>
  <primary_completion_date type="Anticipated">April 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction of Intraoperative bleeding</measure>
    <time_frame>during surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>hemodynamic fluctuation</measure>
    <time_frame>during surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Chronic Sinusitis</condition>
  <arm_group>
    <arm_group_label>1% lidocaine with 1:100000 adrenaline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>high dose adrenaline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1% lidocaine with 1:200,000 adrenaline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>low dose</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>1% lidocaine with 1:100,000 adrenaline</intervention_name>
    <description>high dose</description>
    <arm_group_label>1% lidocaine with 1:100000 adrenaline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>1% lidocaine with 1:200,000 adrenaline</intervention_name>
    <description>1% lidocaine with 1:200,000 adrenaline</description>
    <arm_group_label>1% lidocaine with 1:200,000 adrenaline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  recurrent acute sinusitis, chronic sinusitis, or nasal polyposis

        Exclusion Criteria:

          -  bleeding disorders, under age of 18, history of cardiac disease or on antihypertensive
             medications
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ali Moshaver, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Toronto</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ali Moshaver, MD</last_name>
    <phone>250-276-5050</phone>
    <email>moshaver@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Toronto</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M6R 1B5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ali Moshaver, MD</last_name>
      <phone>250-276-5050</phone>
      <email>moshaver@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Ali Moshaver, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>June 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 26, 2009</study_first_submitted>
  <study_first_submitted_qc>February 26, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 27, 2009</study_first_posted>
  <last_update_submitted>June 29, 2010</last_update_submitted>
  <last_update_submitted_qc>June 29, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 30, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr. A. Moshaver</name_title>
    <organization>University Of Toronto</organization>
  </responsible_party>
  <keyword>Endoscopic sinus surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sinusitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
    <mesh_term>Hemostatics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

